Fact CheckerSign in

NCT05622110Completed

Laparoscopic Incision Closure s in Obese Patients

Laparoscopic Incision Closure Following Gynecological Benign Surgeries in Obese Patients

Source: ClinicalTrials.gov · Last updated 8 Apr 2025

Brief summary (registry, in English)

Several methods for closure of trocar wounds are known in laparoscopic surgery including mostly transcutaneous or subcuticular suture or adhesive paper tape. Studies comparing laparoscopic incision closure in bariatric population are limited .This is a prospective study that will be conducted in a single tertiary medical center. s obese population comprise most of our surgical candidates, and due to the aforementioned, the aim of our study is to compare the outcomes of both techniques in obese women.

Status (registry)
Completed
Study type
Interventional
Enrollment
53 (actual)
First submitted
10 Nov 2022
Start date
2 Dec 2023
Primary completion date
1 Dec 2024
Lead sponsor
The University of Texas Health Science Center, Houston
Diseases
Obesity
NCT number
NCT05622110

What you commit to

  • Study type: Interventional
  • Participants enrolled: 53
  • From 2 Dec 2023 to the primary completion date, 1 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Connective tissue disease

Who the study is looking for

  • \- All women undergoing gynecologic laparoscopic surgery.

Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.